Systemic changes in the immune system of patients with Alzheimer's disease;Systemische veranderungen des immunsystems bei patienten mit Alzheimer- Demenz

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 25-26, 1998, Pages 787-791

  Leblhuber, F ^a   Walli, J ^a   Tilz, G P ^c   Wachter, H ^b,d   Fuchs, D ^b,d  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

^d UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TUMOR NECROSIS FACTOR; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE SYSTEM; PATHOGENESIS; PATHOPHYSIOLOGY; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; IMMUNOLOGY; MALE; MENTAL HEALTH; RADIOGRAPHY;

AGED; ALZHEIMER DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MENTAL STATUS SCHEDULE; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032546690     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024069     Document Type: Article

References (29)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52 (1988), 487-501.
2. Aisen, P. S.: Inflammation and Alzheimer disease. Molec. Chem. Neuropathol. 28 (1996), 83-88.
3. Aisen, P. S., K. L. Davis: Inflammatory mechanism in Alzheimer's disease. Implications for therapy. Amer. J. Psychiatry 151 (1994), 1105-1113.
4. Altstiel, L. D., B. Lawlor, R. Mohs, J. Schmeidler, A. Dalton, P. Mehta, K. Davis: Elevated alpha-1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients. Dementia 6 (1995), 17-20.
5. Araga, S., H. Kagimoto, K. Funamoto, K. Takahashi: Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta neurol. scand. 84 (1991), 259-263.
6. Bauer, J., S. Strauss, B. Volk, M. Berger: Il-6-mediated events in Alzheimer's disease pathology. Immunol.Today 12 (1991), 422.
7. Diez-Ruiz, A., G. P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, D. Fuchs: Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Europ. J. Haematol. 54 (1995), 1-8.
8. Duguid, J. R., C. W. Bohmont, N. Liu, W. W. Tourtelotte: Changes in brain gene expression shared by scrapie and Alzheimer's disease. Proc. Nat. Acad. Sci. USA 86 (1989), 7260-7264.
9. Frei, K., U. V. Malipiero, T. P. Leist et al.: On the cellular source and function of interleukin-6 produced in the central nervous system. Europ. J. Immunol. 19 (1989), 689-694.
10. Gaskin, F., B. S. Kingsley, S. M. Fu: Autoantibodies to neurofibrillary tangels and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody producing cell lines. J. Exp. Med. 1165 (1987), 245-250.
11. Gordon, J., L. Flores-Romo, J. A. Cairns, M. J. Millsum, P. J. Lane, G. D. Johnson, I. C. MacLennan: CD 23: a multi-functional receptor/ lymphokine? Immunol, Today 10 (1989), 153-157.
12. Ishii, T., S. Haga: Immunoelectron microscopic localisation of immunoglobulins in amyloid fibrils of senile plaques. Acta neuropathol. 36 (1976), 245-249.
13. Jellinger, K., W. Danielczyk, P. Fischer, E. Gabriel: Clinico-pathological analysis of dementia disorders in the elderly. J. neurol. Sci. 95 (1990), 239-258.
14. Khachaturian, Z. S.: Diagnosis of Alzheimer's disease. Arch. Neurol. 42 (1985), 1097-1105.
15. Khansari, N., H. D. Whitten, Y. K. Chou, H. H. Funderberg: Immunological Dysfunction in Alzheimer's disease. Clin. Immunol. Immunopathol. 75 (1995), 246-250.
16. Leblhuber, F., J. Walli, G. P. Tilz, H. Wachter, D. Fuchs: Immunologische Befunde bei Patienten mit Alzheimer'scher Demenz. Neuropsychiatrie 10 (1996), 138-139.
17. Licastro, F., L. J. Davis, E. Polazzi, S. Rossi, D. Cucinotta: Serological alpha-1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short term longitudinal study. Alzheimer Dis. ass. Disord. 10 (1996), 192-196.
18. Lopez, O. L., B. S. Rabin, F. J. Huff: Serum autoantibodies in Alzheimer's disease. Acta neurol. scand. 84 (1991), 441-444.
19. Matsubara, E., S. Hirai, M. Amari, M. Shoji, H. Yamaguchi, K. Okamoto, K. Ishiguro, Y. Harigaya, W. Wakabayashi: Alpha-1-Antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann. Neurol. 28 (1990), 561-567.
20. McKhann, G., D. Drachmann, M. Folstein, R. Katzmann, D. Price, E. M. Stadlan: Clinical Diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 34 (1984), 934-944.
21. Pirttilä, T., S. Mattinen, H. Frey: The decrease of CD8-positive lymphocytes in Alzheimer's disease. J. neurol. Sci. 107 (1992), 160-165.
22. Rogers, J., L. C. Kirby, S. R. Hempelman, D. L. Berry, P. L. McGeer, A.W. Kazniak, J. Zalinsky, M. Cofield, L. Mansukhani, P. Wilson, F. Kogan: Clinical trial of indometacin in Alzheimer's disease. Neurology 43 (1993), 1609-1611.
23. Rozemuller, J. M., F. C. Stam, P. Eikelenboom: Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119 (1990), 75-78.
24. Rubin, L. A., D. L. Nelson: The soluble interleucin-2 receptor: biology, functional and clinical application. Ann. Intern. Med. 113 (1990), 619-627.
25. Sapolsky, R. M.: A mechanism for gluocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults. J. Neurosci. 5 (1985), 1228-1232.
26. Shalit, F., B. Sredni, C. Brodie, E. Kott, M. Hberman: T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immunopathol. 75 (1995), 246-250.
27. Steel, D. N., A. S. Whitehead: The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol. Today 15 (1994), 81-88.
28. Stewart, W. F., C. Kawas, M. Corrada, E. J. Metter: Risk of Alzheimer's disease and duration of NSAID use. Neurology 84 (1997), 626-632.
29. Zachhuber, C., F. Leblhuber, K. Jellinger, C. Bancher, M. Drlicek: Histopathologische Untersuchungen bei Demenz - ein Vergleich. Z. Gerontol. Geriat. 30 (1997), 29-33.